Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)

SHE:002898 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	27.83	48.84	87.12	72.27	113.31	58.08
Trading Asset Securities	-	-	2.14	-	-	-
Cash & Short-Term Investments	27.83	48.84	89.26	72.27	113.31	58.08
Cash Growth	-59.34%	-45.28%	23.51%	-36.22%	95.10%	-39.67%
Accounts Receivable	76.28	99.68	55.27	88.85	84.98	80.87
Other Receivables	10.91	4.03	14.71	19.68	33.83	8.51
Receivables	87.19	103.7	69.98	108.53	118.81	89.38
Inventory	99.6	94.08	88.87	63.97	52.98	62.74
Prepaid Expenses	-	-	-	-	-	0.01
Other Current Assets	38.53	3.21	8.19	9.59	4.05	32.69
Total Current Assets	253.15	249.83	256.3	254.36	289.14	242.89
Property, Plant & Equipment	387.83	402.23	352.11	394.25	405.59	408.8
Long-Term Investments	4.9	4.9	69.86	62.28	45.19	38.66
Other Intangible Assets	69.67	67.71	67	67.77	70.46	74.65
Long-Term Deferred Tax Assets	2.34	3.71	1.96	13.58	18.57	21.57
Long-Term Deferred Charges	60.1	59.16	45.74	36.7	33.23	23.5
Other Long-Term Assets	19.56	20.68	20.88	19.08	20.61	3.89
Total Assets	797.54	808.22	813.84	848.01	882.78	813.96
Accounts Payable	39.76	62.31	63.53	94.47	94.15	64.71
Accrued Expenses	5.13	21.03	17.55	22.39	14.55	10.84
Short-Term Debt	104.95	128.13	90.05	100.06	100.12	90
Current Portion of Long-Term Debt	-	6.27	11.9	29.63	28.86	1.79
Current Portion of Leases	-	0.5	0.36	0.24	0.89	-
Current Income Taxes Payable	1.11	-	0.02	0.75	0.74	0.17
Current Unearned Revenue	34.63	11.51	11.53	23.53	8.24	8.88
Other Current Liabilities	122.75	25.27	32.08	25.38	19.03	13.87
Total Current Liabilities	308.33	255.02	227.01	296.45	266.58	190.24
Long-Term Debt	8	29.86	25.08	13.32	42.91	28.26
Long-Term Leases	1.73	0.33	0.04	0.18	0.27	-
Long-Term Unearned Revenue	2.9	2.6	2.84	3.08	3.33	3.42
Long-Term Deferred Tax Liabilities	9.78	9.62	9.76	8.63	6.04	5.03
Other Long-Term Liabilities	6.34	11.51	13.23	-	-	-
Total Liabilities	337.07	308.95	277.96	321.67	319.12	226.96
Common Stock	176	176	176	176	176	176
Additional Paid-In Capital	288.47	288.47	288.47	288.47	288.47	288.47
Retained Earnings	-5.65	34.75	71.41	61.88	99.19	122.53
Comprehensive Income & Other	1.66	0.06	-	-	-	-
Shareholders' Equity	460.47	499.28	535.88	526.35	563.66	587
Total Liabilities & Equity	797.54	808.22	813.84	848.01	882.78	813.96
Total Debt	114.68	165.09	127.42	143.43	173.05	120.05
Net Cash (Debt)	-86.84	-116.25	-38.16	-71.16	-59.74	-61.97
Net Cash Per Share	-0.49	-0.66	-0.22	-0.40	-0.34	-0.35
Filing Date Shares Outstanding	176	176	176	176	176	176
Total Common Shares Outstanding	176	176	176	176	176	176
Working Capital	-55.18	-5.19	29.29	-42.09	22.57	52.65
Book Value Per Share	2.62	2.84	3.04	2.99	3.20	3.34
Tangible Book Value	390.81	431.56	468.89	458.58	493.21	512.35
Tangible Book Value Per Share	2.22	2.45	2.66	2.61	2.80	2.91
Buildings	-	301.56	311.75	335.26	323.12	278.98
Machinery	-	226.12	213.31	207.43	194.92	161.46
Construction In Progress	-	5.89	1.44	1.38	9.21	65.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.